Puma Biotechnology (PBYI)Director sold ~$39K

~$39K

Approx. value · 12K sh @ $3.40

75K

Holds after · shares reported

Traded

Jun 13, 2025

Filed

Jun 17, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 13, 2025 · this disclosureInsiderDirector sold ~$39K of PBYI shares in the open market

What came next

1. Jun 13, 2025Insider · 5 peopleInsiders: 5 sales (~$272K)
2. Jul 8, 2025Insider · 3 peopleInsiders: 3 sales (~$126K)
3. Jul 9, 2025Insider · 3 peopleInsiders: 3 sales (~$102K)
4. Jul 18, 2025InsiderDirector sold ~$91K of PBYI shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Puma Biotechnology

For Puma Biotechnology, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PBYI page.

Other recent filings by Allison Dorval, Director

• SEC Form 4 at Puma Biotechnology (PBYI)Jun 16, 2026

The full history of Allison Dorval, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Puma Biotechnology

• SEC Schedule 13DOct 6, 2026
• SEC Form 4Sep 17, 2026
• SEC Form 4Sep 17, 2026
• SEC Form 4Jul 9, 2026
• SEC Form 4Jul 9, 2026
• SEC Form 4Jul 9, 2026

Everything OQRO holds on this company is on its PBYI page.